ARCHIVES

Newest NIH Institute, NIBIB, Gets An Acting Director.

This article is from The Cancer Letter archive.

Vol. 27 No. 19 | May 11, 2001

Download PDF Visit The Full Archive

Related Articles

DCT Programs Status Reported to Board

July 5, 1985

ELM Wins ACCC Management Contract Over ORC, Others

February 21, 1992

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

June 3, 2011

Senate Subcommittee Approves 3.5 Percent Increase for NIH.

June 29, 2007

Two More Treatment Programs Moved To DCT; Rauscher Ponders Fate of Cooperative Groups

April 18, 1975

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995